Viral inactivation market will experience a noticeable growth during the forecast period 2019 – 2025

Inactivation or removal of viral using techniques such as pH, disinfectants, heat treatment, detergents ultraviolet radiation, ionizing radiation, desiccation, antiseptics and organic solvents in which virus may present in the final product but in non-infective form is called viral inactivation. The other methods of viral inactivation include ultraviolet-C (UVC) light which is low-dose radiation at a wavelength of 254 nm. Further, UVC is an effective method for non-enveloped viruses and high temperature short-time (HTST) treatment for inactivation. Using virus inactivation method during production can alleviate some concerns about potentially infectious, adventitious, or endogenous agents. Viral inactivation is used widely in the blood plasma industry, vaccines & therapeutics, tissues & tissue products, and stem cell products. The viral inactivation method is also being used by academic research institutes, pharmaceutical & biotechnology companies and contract research organizations (CRO). Viral Inactivation is a part of viral clearance that is mandatory for any drug development which makes viral inactivation a useful part of the drug development process.

Browse the full report of Viral Inactivation Market by Product Type (Kits and Reagents, Systems, and Services), by Application (Vaccines and Therapeutics, Blood and Blood Products, Stem Cell Products, Tissue and Tissue Products, and Others), by End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CROs) and Others) - Industry Size, Share, Trends, Growth and Forecasts, 2019–2025 at https://www.omrglobal.com/industry-reports/viral-inactivation-market/

The global viral inactivation market growth is influenced by the rising number of new drug launches, fast growth in pharmaceutical & biotechnology industries, strong R&D investments in the life sciences industry and growing government support for pharmaceutical & biotechnology industries. The concern about bioterrorism and the rapid transport of viral agents by the traveling public is working as a motivation behind the increased development and R&D in viral inactivation field.

Increased demand for advanced healthcare infrastructure and life science research in Asia-Pacific is expected to lead the global viral inactivation market. Key players in the viral inactivation market include WuXi PharmaTech (Cayman) Inc. (China), Rad Source Technologies (U.S.), Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Viral Inactivated Plasma Systems SA (Switzerland), Merck group (Germany), Parker Hannifin (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), and Danaher Corp (U.S.).

Request a free report sample @ https://www.omrglobal.com/request-sample/?id=20031

Current Market Trends Covered in the market report:
• Increased investment for the development of the life sciences segment driving the viral inactivation market.
• UV-C new viral inactivation technology that is simple to integrate into a purification process and has less critical process parameters.
• A lab-scale prototype viral inactivation system for the continuous process was designed, built, and characterized to be used for viral inactivation.
• Cadence virus inactivation system is recently introduced for the commercial use which performs low pH virus inactivation in a continuous incoming elution stream with minimum operator involvement.

The Report Global Viral Inactivation Market Segmentation
By Product Type
• Kits & Reagents
• Systems
• Services
By Application
• Vaccines and Therapeutics
• Blood and Blood Products
• Stem Cell Products
• Tissue and Tissue Products
• Others (Cellular and Gene Therapy Products)
By End-User
• Pharmaceutical and Biopharmaceutical Companies
• Contract Research Organizations
• Others (Research Institutes)
By Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

To know more about this study, talk to our analyst @ https://www.omrglobal.com/inquiry-before-buying/?id=20031

The Report Covers:
Analysis of regional regulations and other government policies impacting the global viral inactivation market.
Insights about market determinants which are stimulating the global viral inactivation
Detailed and extensive market segments with regional distribution of forecast revenues.
Extensive profiles and recent developments of market players.

Table of Content:
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
....................

Read continue @ https://www.omrglobal.com/industry-reports/viral-inactivation-market/

Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global:+1-646-755-7667
Indore-India-452010
Web: www.omrglobal.com

Orion Market Research (OMR) is a market research company that endeavors to provide exclusive blend of qualitative and quantitative market research reports to global clients. Our organization helps both multinational and domestic enterprises bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of markets providing insights and market outlook to global clients.

This release was published on openPR.